Author Question: The heart of social welfare policy in the United States and the largest nondefense item in the ... (Read 87 times)

tichca

  • Hero Member
  • *****
  • Posts: 554
The heart of social welfare policy in the United States and the largest nondefense item in the federal budget is
 
  a. Social Security.
  b. Aid to Families with Dependent Children.
  c. food stamps.
  d. the Job Training Partnership Act.
  e. Great Society program

Question 2

An example of the complexity of environmental regulation is the increased use of _______________ policies that allow companies to build facilities in one area that may pollute if they lower pollution in another area.
 
  a. environmental impact
  b. dynamic
  c. logrolling
  d. offset
  e. surcharge



anyusername12131

  • Sr. Member
  • ****
  • Posts: 327
Answer to Question 1

a

Answer to Question 2

d



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Urine turns bright yellow if larger than normal amounts of certain substances are consumed; one of these substances is asparagus.

Did you know?

About 60% of newborn infants in the United States are jaundiced; that is, they look yellow. Kernicterus is a form of brain damage caused by excessive jaundice. When babies begin to be affected by excessive jaundice and begin to have brain damage, they become excessively lethargic.

Did you know?

Cucumber slices relieve headaches by tightening blood vessels, reducing blood flow to the area, and relieving pressure.

Did you know?

Signs and symptoms that may signify an eye tumor include general blurred vision, bulging eye(s), double vision, a sensation of a foreign body in the eye(s), iris defects, limited ability to move the eyelid(s), limited ability to move the eye(s), pain or discomfort in or around the eyes or eyelids, red or pink eyes, white or cloud spots on the eye(s), colored spots on the eyelid(s), swelling around the eyes, swollen eyelid(s), and general vision loss.

Did you know?

Bisphosphonates were first developed in the nineteenth century. They were first investigated for use in disorders of bone metabolism in the 1960s. They are now used clinically for the treatment of osteoporosis, Paget's disease, bone metastasis, multiple myeloma, and other conditions that feature bone fragility.

For a complete list of videos, visit our video library